应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02197 三叶草生物-B
已收盘 03-30 16:08:18
1.660
-0.020
-1.19%
最高
1.770
最低
1.660
成交量
1,625万
今开
1.700
昨收
1.680
日振幅
6.55%
总市值
21.47亿
流通市值
21.47亿
总股本
12.93亿
成交额
2,777万
换手率
1.26%
流通股本
12.93亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 三叶草生物-B(02197)跌8% 22年收入减少39%、归母亏损收窄59% 期末现金结余减少9.8亿元
智通财经 · 03-29 10:43
港股异动 | 三叶草生物-B(02197)跌8% 22年收入减少39%、归母亏损收窄59% 期末现金结余减少9.8亿元
三叶草生物-B盘中异动 早盘股价大跌5.52%报1.730港元
自选股智能写手 · 03-29 10:20
三叶草生物-B盘中异动 早盘股价大跌5.52%报1.730港元
三叶草生物-B(02197)发布年度业绩,股东应占亏损24.52亿元 同比收窄59.25%
智通财经 · 03-29 07:06
三叶草生物-B(02197)发布年度业绩,股东应占亏损24.52亿元 同比收窄59.25%
小摩上调福莱特玻璃评级至“增持”,目标价升至25.25港元
智通财经网 · 03-24
小摩上调福莱特玻璃评级至“增持”,目标价升至25.25港元
港股生物医药股跌幅扩大,云顶新耀-B跌超12%
老虎资讯综合 · 03-20
港股生物医药股跌幅扩大,云顶新耀-B跌超12%
三叶草生物-B盘中异动 股价大跌5.00%报1.920港元
自选股智能写手 · 03-20
三叶草生物-B盘中异动 股价大跌5.00%报1.920港元
三叶草生物-B(02197.HK)将于3月28日举行董事会会议以审批全年业绩
格隆汇资讯 · 03-16
三叶草生物-B(02197.HK)将于3月28日举行董事会会议以审批全年业绩
三叶草生物-B盘中异动 早盘股价大涨5.31%
自选股智能写手 · 03-14
三叶草生物-B盘中异动 早盘股价大涨5.31%
三叶草生物-B盘中异动 下午盘快速跳水5.04%
自选股智能写手 · 03-08
三叶草生物-B盘中异动 下午盘快速跳水5.04%
三叶草生物-B(02197)股价下跌5%,现价港币$2.28
阿斯达克财经 · 03-08
三叶草生物-B(02197)股价下跌5%,现价港币$2.28
智通港股通占比异动统计|3月7日
智通财经 · 03-07
智通港股通占比异动统计|3月7日
*高盛微升三叶草生物(02197)目标价2%至3.95港元 维持“中性”评级
凤凰网港股 · 02-23
*高盛微升三叶草生物(02197)目标价2%至3.95港元 维持“中性”评级
【港股通】三叶草生物(02197)午后升至6.15% 获瑞信上调其评级与目标价
凤凰网港股 · 02-22
【港股通】三叶草生物(02197)午后升至6.15% 获瑞信上调其评级与目标价
三叶草生物-B(02197)股价上升8.462%,现价港币$2.82
阿斯达克财经 · 02-22
三叶草生物-B(02197)股价上升8.462%,现价港币$2.82
抗疫概念股拉升,国内新冠疫情不确定性或带动新冠小分子需求
格隆汇 · 02-22
抗疫概念股拉升,国内新冠疫情不确定性或带动新冠小分子需求
《大行报告》瑞信升三叶草生物-B(02197.HK)评级至“跑赢大市” 目标价上调至3.4元
阿斯达克财经 · 02-22
《大行报告》瑞信升三叶草生物-B(02197.HK)评级至“跑赢大市” 目标价上调至3.4元
港股抗疫板块短线拉升
和讯 · 02-22
港股抗疫板块短线拉升
港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议
智通财经 · 02-22
港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议
三叶草生物-B开盘涨超9% 达成进口四价季节性流感疫苗分销协议
智通财经 · 02-20
三叶草生物-B开盘涨超9% 达成进口四价季节性流感疫苗分销协议
加载更多
公司概况
公司名称:
三叶草生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"三叶草生物-B","latestPrice":1.66,"timestamp":1680163698015,"preClose":1.68,"halted":0,"volume":16253250,"delay":0,"floatShares":1293314233,"shares":1293314233,"eps":-5.9207873,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"03-30 16:08:18","open":1.7,"high":1.77,"low":1.66,"amount":27773476,"amplitude":0.065476,"askPrice":1.67,"askSize":148000,"bidPrice":1.66,"bidSize":144500,"shortable":3,"etf":0,"ttmEps":-5.729586731219092,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1680226200000},"adr":0,"listingDate":1636041600000,"adjPreClose":1.68,"volumeRatio":1.322527,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"2323424657","title":"港股异动 | 三叶草生物-B(02197)跌8% 22年收入减少39%、归母亏损收窄59% 期末现金结余减少9.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2323424657","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2323424657?lang=zh_CN&edition=full","pubTime":"2023-03-29 10:43","pubTimestamp":1680057823,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,三叶草生物-B绩后走低,早盘跌约8%。22年,公司实现其他收入及收益同比减少39.25%;归母亏损同比减少59.25%;期末现金及银行结余约18.6亿元,相比上年减少约9.8亿元。截至发稿,三叶草生物跌8.20%,报1.68港元,成交额0.35亿港元。3月29日早,三叶草生物发布2022年年度业绩。期内实现其他收入及收益2324.6万元,同比减少39.25%;母公司拥有人应占亏损24.52亿元,同比减少59.25%;每股亏损2.22元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/901077.html","is_publish_highlight":false},{"id":"2323245589","title":"三叶草生物-B盘中异动 早盘股价大跌5.52%报1.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2323245589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2323245589?lang=zh_CN&edition=full","pubTime":"2023-03-29 10:20","pubTimestamp":1680056455,"startTime":"0","endTime":"0","summary":"2023年03月29日早盘10时20分,三叶草生物-B股票出现异动,股价快速跳水5.52%。截至发稿,该股报1.730港元/股,成交量525.95万股,换手率0.41%,振幅7.65%。三叶草生物-B股票所在的生物技术行业中,整体跌幅为0.07%。消息层面,截至10时20分,《三叶草生物-B发布年度业绩,股东应占亏损24.52亿元 同比收窄59.25%》资讯为影响三叶草生物-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032910205582bece69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032910205582bece69&s=b","is_publish_highlight":false},{"id":"2323179215","title":"三叶草生物-B(02197)发布年度业绩,股东应占亏损24.52亿元 同比收窄59.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2323179215","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2323179215?lang=zh_CN&edition=full","pubTime":"2023-03-29 07:06","pubTimestamp":1680044794,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三叶草生物-B 发布截至2022年12月31日止年度业绩,该集团取得其他收入及收益人民币2324.6万元,同比减少39.25%;母公司拥有人应占亏损24.52亿元,同比减少59.25%;每股亏损2.22元。研发开支由截至2021年12月31日止年度的18.26亿元减少3.61亿元至截至2022年12月31日止年度的14.65亿元。年内亏损由截至2021年12月31日止年度的60.16亿元减少35.64亿元至截至2022年12月31日止年度的24.52亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/900986.html","is_publish_highlight":false},{"id":"2321137556","title":"小摩上调福莱特玻璃评级至“增持”,目标价升至25.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2321137556","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2321137556?lang=zh_CN&edition=full","pubTime":"2023-03-24 08:35","pubTimestamp":1679618100,"startTime":"0","endTime":"0","summary":"根据2023年3月23日披露数据,新特能源、康龙化成、长城汽车港股通持股占比增加值最大,分别增加0.56%、0.45%、0.43%;恒生中国企业、南方恒生科技、山东新华制药股份港股通持股占比减少值最大,分别减少-3.69%、-1.31%、-0.56%。在最近有统计数据的5个交易日内,新特能源、叮当健康、金山云港股通持股占比增加值最大,分别增加3.00%、2.30%、2.00%;宝新金融、大家乐集团、东方甄选港股通持股占比减少值最大,分别减少-13.02%、-1.84%、-1.33%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-03-24/doc-imymxpan3003067.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-03-24/doc-imymxpan3003067.shtml","is_publish_highlight":false},{"id":"1170333750","title":"港股生物医药股跌幅扩大,云顶新耀-B跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170333750","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1170333750?lang=zh_CN&edition=full","pubTime":"2023-03-20 10:06","pubTimestamp":1679277991,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true},{"id":"2320731905","title":"三叶草生物-B盘中异动 股价大跌5.00%报1.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2320731905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2320731905?lang=zh_CN&edition=full","pubTime":"2023-03-20 09:45","pubTimestamp":1679276725,"startTime":"0","endTime":"0","summary":"2023年03月20日早盘09时45分,三叶草生物-B股票出现波动,股价大幅下挫5.00%。截至发稿,该股报1.920港元/股,成交量269.05万股,换手率0.21%,振幅5.94%。资金方面,该股资金流入65.0105万港元,流出281.56万港元。三叶草生物-B股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,百奥赛图-B、欧康维视生物-B、华康生物医学涨幅较大,振幅较大的相关个股有云顶新耀-B、基石药业-B、巨子生物,振幅分别为8.39%、7.73%、6.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032009452582bc55d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032009452582bc55d6&s=b","is_publish_highlight":false},{"id":"2319335512","title":"三叶草生物-B(02197.HK)将于3月28日举行董事会会议以审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2319335512","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2319335512?lang=zh_CN&edition=full","pubTime":"2023-03-16 16:42","pubTimestamp":1678956129,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨三叶草生物-B(02197.HK)公告,董事会会议将于2023年3月28日举行,以考虑及批准公司及其附属公司截至2022年12月31日止财政年度的全年业绩及其发布,以及考虑派付末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164213841a4aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164213841a4aa6&s=b","is_publish_highlight":false},{"id":"2319049135","title":"三叶草生物-B盘中异动 早盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319049135","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2319049135?lang=zh_CN&edition=full","pubTime":"2023-03-14 09:46","pubTimestamp":1678758399,"startTime":"0","endTime":"0","summary":"2023年03月14日早盘09时46分,三叶草生物-B股票出现异动,股价急速拉升5.31%。截至发稿,该股报2.181港元/股,成交量190.1万股,换手率0.15%,振幅5.80%。三叶草生物-B股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,乐普生物-B、荣昌生物-B、康宁杰瑞制药-B涨幅较大,振幅较大的相关个股有乐普生物-B、荣昌生物-B、康宁杰瑞制药-B,振幅分别为23.67%、9.19%、7.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230314094639846ddd2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230314094639846ddd2a&s=b","is_publish_highlight":false},{"id":"2317476313","title":"三叶草生物-B盘中异动 下午盘快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2317476313","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2317476313?lang=zh_CN&edition=full","pubTime":"2023-03-08 14:29","pubTimestamp":1678256992,"startTime":"0","endTime":"0","summary":"2023年03月08日下午盘14时29分,三叶草生物-B股票出现异动,股价急速下挫5.04%。截至发稿,该股报2.280港元/股,成交量827.133万股,换手率0.64%,振幅5.00%。三叶草生物-B股票所在的生物技术行业中,整体跌幅为2.56%。其相关个股中,创胜集团-B、和誉-B、贝康医疗-B涨幅较大,振幅较大的相关个股有迈博药业-B、创胜集团-B、加科思-B,振幅分别为16.33%、13.06%、10.40%。该公司的主营业务是为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081429568352cf28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081429568352cf28&s=b","is_publish_highlight":false},{"id":"2317768594","title":"三叶草生物-B(02197)股价下跌5%,现价港币$2.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2317768594","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2317768594?lang=zh_CN&edition=full","pubTime":"2023-03-08 14:29","pubTimestamp":1678256940,"startTime":"0","endTime":"0","summary":"[下跌股]三叶草生物-B(02197) 股价在下午02:29比前收市价下跌5%,现股价为港币$2.28。至目前为止,今日最高价为$2.4,而最低价为$2.28。总成交量为827.083万股,总成交金额为港币$1.923千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2303084954/aamm-all-category","is_publish_highlight":false},{"id":"2317306484","title":"智通港股通占比异动统计|3月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2317306484","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2317306484?lang=zh_CN&edition=full","pubTime":"2023-03-07 08:35","pubTimestamp":1678149337,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,根据2023年3月2日披露数据,南方恒生科技、中兴通讯、长城汽车港股通持股占比增加值最大,分别增加1.05%、0.75%、0.73%;恒生中国企业、盈富基金、国美零售港股通持股占比减少值最大,分别减少-5.69%、-4.09%、-0.80%。在最近有统计数据的5个交易日内,长城汽车、力劲科技、中兴通讯港股通持股占比增加值最大,分别增加3.19%、2.05%、2.00%;绿色经济、JS环球生活、国美零售港股通持股占比减少值最大,分别减少-1.71%、-1.19%、-1.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/887677.html","is_publish_highlight":false},{"id":"2313047720","title":"*高盛微升三叶草生物(02197)目标价2%至3.95港元 维持“中性”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2313047720","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2313047720?lang=zh_CN&edition=full","pubTime":"2023-02-23 09:38","pubTimestamp":1677116315,"startTime":"0","endTime":"0","summary":"高盛将三叶草生物(02197)目标价从3.86港元上调2%至3.95港元,维持“中性”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=83de678797dfb3ac2c1c6486ab577f6c","is_publish_highlight":false},{"id":"2313942730","title":"【港股通】三叶草生物(02197)午后升至6.15% 获瑞信上调其评级与目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2313942730","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2313942730?lang=zh_CN&edition=full","pubTime":"2023-02-22 14:40","pubTimestamp":1677048047,"startTime":"0","endTime":"0","summary":"三叶草生物(02197)逆市向上,午后升幅扩大,最新报2.76港元,涨6.15%,成交额1.45亿港元。瑞信发研报指,三叶草生物与国光生技签订独家协议,将会在内地分销四价季节性流感疫苗AdimFlu-S,而预计商业分销将在今年下半年进行。三叶草生物定价策略是维持每剂约200元人民币,并认为AdimFlu-S疫苗在内地销量或超过20亿元人民币,这将取决于集团的商业策略和努力。该行将公司评级由“中性”升至“跑赢大市”,2023-24年度每股盈测分别-81%/+21%,以反映新增AdimFlu-S疫苗及新冠疫苗定价下调因素,目标价由3港元上调至3.4港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=fc9e44997791ce6a66b1ac97c8c82898","is_publish_highlight":false},{"id":"2313941930","title":"三叶草生物-B(02197)股价上升8.462%,现价港币$2.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2313941930","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2313941930?lang=zh_CN&edition=full","pubTime":"2023-02-22 14:18","pubTimestamp":1677046680,"startTime":"0","endTime":"0","summary":"[上升股]三叶草生物-B(02197) 股价在下午02:18比前收市价上升8.462%,现股价为港币$2.82。至目前为止,今日最高价为$2.82,而最低价为$2.61。总成交量为3.871千万股,总成交金额为港币$1.051亿。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2302221359/aamm-all-category","is_publish_highlight":false},{"id":"2313506460","title":"抗疫概念股拉升,国内新冠疫情不确定性或带动新冠小分子需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2313506460","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2313506460?lang=zh_CN&edition=full","pubTime":"2023-02-22 10:27","pubTimestamp":1677032873,"startTime":"0","endTime":"0","summary":"中信证券发布研报称,近日我国本土首次检出XBB.1.5,若未来国内新冠疫情反复,新冠小分子需求有望增加。","market":"hk","thumbnail":"https://img3.gelonghui.com/660c9-f7438420-ba25-405d-8c96-aeffce9049ba.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/660c9-f7438420-ba25-405d-8c96-aeffce9049ba.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/581378","is_publish_highlight":false},{"id":"2313622250","title":"《大行报告》瑞信升三叶草生物-B(02197.HK)评级至“跑赢大市” 目标价上调至3.4元","url":"https://stock-news.laohu8.com/highlight/detail?id=2313622250","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2313622250?lang=zh_CN&edition=full","pubTime":"2023-02-22 10:18","pubTimestamp":1677032280,"startTime":"0","endTime":"0","summary":"瑞信发表报告指,三叶草生物-B与国光生技签订独家协议,将会在内地分销四价季节性流感疫苗AdimFlu-S,而预计商业分销将在今年下半年进行。该行指,三叶草生物定价策略是维持每剂约200元人民币,并认为AdimFlu-S疫苗在内地销量或超过20亿元人民币,这将取决于集团的商业策略和努力。该行将集团2023至2024年度每股盈测分别下调81%及上调21%,以反映新增AdimFlu-S疫苗及新冠疫苗定价下调的因素,目标价则由3元上调至3.4元,评级由“中性”升至“跑赢大市”。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220113153515477_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220113153515477_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1246648/latest-news/HK6","is_publish_highlight":false},{"id":"2313061701","title":"港股抗疫板块短线拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2313061701","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2313061701?lang=zh_CN&edition=full","pubTime":"2023-02-22 10:09","pubTimestamp":1677031783,"startTime":"0","endTime":"0","summary":"快讯摘要港股抗疫板块短线拉升:港股抗疫板块短线拉升,山东新华制药涨超14%,三叶草生物涨超4%,康希诺生物、歌礼制药等跟涨。快讯正文港股抗疫板块短线拉升:港股抗疫板块短线拉升,山东新华制药涨超14%,三叶草生物涨超4%,康希诺生物、歌礼制药等跟涨。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022210153684117d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022210153684117d2e&s=b","is_publish_highlight":false},{"id":"2313406962","title":"港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2313406962","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2313406962?lang=zh_CN&edition=full","pubTime":"2023-02-22 09:46","pubTimestamp":1677030416,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,三叶草生物-B再涨超7%,截至发稿,涨4.23%,报2.71港元,成交额3493.52万港元。消息面上,三叶草生物近日发布公告称,公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后,在孟加拉国、巴西和菲律宾商业化AdimFlu-S,并有望与国光生技合作开发其他候选疫苗,包括下一代流感疫苗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/880258.html","is_publish_highlight":false},{"id":"2312853758","title":"三叶草生物-B开盘涨超9% 达成进口四价季节性流感疫苗分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2312853758","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2312853758?lang=zh_CN&edition=full","pubTime":"2023-02-20 09:48","pubTimestamp":1676857694,"startTime":"0","endTime":"0","summary":"截至发稿,三叶草生物-B涨9.20%。根据公告,该公司与国光生技达成AdimFlu-S在中国分销的独家协议,该款疫苗是内地目前唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后,在孟加拉国、巴西和菲律宾商业化AdimFlu-S,并有望与国光生技合作开发其他候选疫苗,包括下一代流感疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230220100027825f03da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230220100027825f03da&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1429},{"period":"1month","weight":-0.3307},{"period":"3month","weight":-0.3684},{"period":"6month","weight":-0.1295},{"period":"1year","weight":-0.7614},{"period":"ytd","weight":-0.3514}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":0.0307},{"period":"1month","weight":0.0125},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1724},{"period":"1year","weight":-0.0791},{"period":"ytd","weight":0.0208}],"name":"三叶草生物-B","description":null,"exchange":"SEHK","nameEN":"CLOVER BIO-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.12.1","shortVersion":"4.12.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三叶草生物-B,02197,三叶草生物-B股票,三叶草生物-B股票老虎,三叶草生物-B股票老虎国际,三叶草生物-B行情,三叶草生物-B股票行情,三叶草生物-B股价,三叶草生物-B股市,三叶草生物-B股票价格,三叶草生物-B股票交易,三叶草生物-B股票购买,三叶草生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}